Comment to: Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study-determination of immunogenicity.
作者信息
Lenders Malte, Brand Eva
机构信息
Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Münster, Münster, Germany
Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Münster, Münster, Germany.
出版信息
J Med Genet. 2024 May 21;61(6):531-533. doi: 10.1136/jmg-2023-109818.
PMID:38538083
Abstract
摘要
Zotero 插件